comparemela.com

Latest Breaking News On - Yi chen hc wainwright co - Page 1 : comparemela.com

Ortho Clinical Diagnostics Holdings plc (OCDX) Q2 2021 Earnings Call Transcript

Ortho Clinical Diagnostics Holdings plc (OCDX) Q2 2021 Earnings Call Transcript
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.

Inovio Pharmaceuticals (INO) Q1 2021 Earnings Call Transcript

Inovio Pharmaceuticals (INO) Q1 2021 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. Inovio Pharmaceuticals (NASDAQ: INO) Operator Good day, and welcome to the Inovio Pharmaceuticals first-quarter 2021 financial results conference call. [Operator instructions] Please note, this event is being recorded. I d now like to turn the conference over to Ben Matone, senior director of investor relations. Please go ahead. Ben Matone Senior Director of Investor Relations Thank you, operator. Thank you for joining the Inovio first-quarter 2021 earnings conference call. Joining me on today s call are Dr. Joseph Kim, president and CEO; Mr.

Opko Health (OPK) Q4 2020 Earnings Call Transcript

Opko Health (OPK) Q4 2020 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. Opko Health (NASDAQ: OPK) Ladies and gentlemen, thank you for standing by, and welcome to the Opko Health fourth-quarter 2020 financial results conference call. [Operator instructions] I would now like to hand the conference to speaker today, Yvonne Briggs, LHA investor relations. Please go ahead ma am. Yvonne Briggs LHA Investor Relations Thank you, operator and good afternoon. This is Yvonne Briggs with LHA. Thank you all for joining today s call to discuss Opko Health financial results for the fourth quarter of 2020. I d like to remind you that any statements made during this call by management other than statements of historical fact will be considered forward-looking and as such, will be subject to risks and uncertainties that could materially affect the company s expected results.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.